Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles
Sponsor: Northwestern University
Summary
The purpose of this study is to compare the effectiveness of Botox® (Onabotulinum Toxin A) versus Xeomin® (incobotulinum toxin A) for the treatment of forehead and glabellar (vertical lines between the eyebrows) wrinkles.
Official title: Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial
Key Details
Gender
All
Age Range
20 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2013-11
Completion Date
2025-12
Last Updated
2025-01-31
Healthy Volunteers
Yes
Conditions
Interventions
Onabotulinum Toxin A
Incobotulinum Toxin A
Locations (1)
Northwestern University Department of Dermatology
Chicago, Illinois, United States